[HTML][HTML] Lengua gigante condicionante de disfagia en paciente con amiloidosis de cadenas ligeras

JJ Gómez-Piña, DM Quiroz… - Revista Médica del …, 2023 - ncbi.nlm.nih.gov
Conclusiones: el abordaje de pacientes con macroglosia es complejo, debido a las diversas
posibilidades diagnósticas, que incluyen causas endocrinológicas, neoplásicas e, incluso …

[PDF][PDF] Clinical characterization and outcomes of a cohort of colombian patients with AL Amyloidosis

CSO Ospina - 2023 - pdfs.semanticscholar.org
Clinical characterization and outcomes of a cohort of colombian patients with amyloid light
chain Amyloidosis Page 1 Colombia Médica | 1/13 Sep 30 - 2023 http://doi.org/10.25100/cm.v54i3.5667 …

[HTML][HTML] Cardiac amyloidosis in the developing world: Disease burden, management challenges and proposed approach

S Singh, A Batta, R Tandon… - Heart Failure Journal of …, 2023 - journals.lww.com
Cardiac amyloidosis (CA) is an underdiagnosed disease with rapid progression and short
overall survival. Despite therapeutic advances, resource-limited settings including India are …

[HTML][HTML] Gelsolin amyloidosis: From genealogy to clinical features

T Mustonen - 2022 - helda.helsinki.fi
Amyloid diseases, in general, cause formation and deposition of insoluble amyloid fibrils
either locally or systemically, disrupting normal organ function. Gelsolin amyloidosis is an …

Impact of light chain isotype on clinical features and outcomes in systemic AL amyloidosis

MB Hopson, D Bhutani, S Sarkaria… - Leukemia & …, 2022 - Taylor & Francis
We performed a retrospective cohort study in AL amyloidosis to investigate the impact of
light chain (LC) isotype on clinical features in 112 consecutive patients. Patients with kappa …

(18) F-sodium fluoride PET in multiple myeloma: Linking cancer to atherosclerosis?

DC Benz, RR Buechel, S Dorbala - Journal of Nuclear Cardiology, 2021 - Springer
Multiple myeloma (MM) is a hematologic malignancy of plasma cells and is characterized by
end-organ damage (eg, hypercalcemia, renal dysfunction, anemia, or lytic bone lesions) due …

Advanced Case of Cardiac Amyloidosis Presents With Chronic Diarrhea

A Mahmoud, M Osama, R Yasser, B Manal… - Cureus, 2022 - search.proquest.com
Late diagnosis of light chain (AL) amyloidosis can lead to catastrophic consequences on the
quality of life of affected patients and overall disease prognosis. Therefore, clinicians should …

НЕФРОТИЧЕСКИЙ СИНДРОМ: ПРИЧИНЫ И ДИФФЕРЕНЦИАЛЬНЫЙ ДИАГНОЗ (ЧАСТЬ 1)

СВ МОИСЕЕВ, ИН БОБКОВА… - КЛИНИЧЕСКАЯ …, 2023 - elibrary.ru
Нефротический синдром (НС), характеризующий протеинурией> 3, 5 г/сут и
гипоальбуминемией (±отеками и дислипидемией)-ведущее проявление заболеваний …

[HTML][HTML] Нарушения гемостаза у пациентов с системным AL-амилоидозом

ИГ Рехтина, ВА Хышова, НИ Зозуля… - Терапевтический …, 2023 - cyberleninka.ru
Цель. Проанализировать частоту и характер геморрагических и тромботических
осложнений у больных системным AL-амилоидозом и сопоставить с лабораторными …

AL amyloidosis: current concepts

JA Lacouture-Fierro, L Mejía-Buriticá… - Medicina & …, 2022 - medigraphic.com
Systemic amyloidosis constitutes a group of diseases with diverse etiologies characterized
by the synthesis of proteins with defective folding, capable of aggregating and depositing in …